We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
301
Sanofi
SNY
$104B
$33.6M 0.06%
774,746
+83,399
+12% +$3.68M
RSG icon
302
Republic Services
RSG
$65.7B
$33.5M 0.06%
464,846
+48,864
+12% +$3.58M
XEL icon
303
Xcel Energy
XEL
$48.8B
$33M 0.06%
669,099
+37,712
+6% +$1.89M
IWP icon
304
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$32.7M 0.06%
575,392
+64,294
+13% +$3.91M
STE icon
305
Steris
STE
$23.1B
$32.6M 0.06%
304,745
+2,200
+0.7% +$246K
GS icon
306
Goldman Sachs
GS
$303B
$32.4M 0.06%
193,949
-66,624
-26% -$13.4M
PAGP icon
307
Plains GP Holdings
PAGP
$4.9B
$32.2M 0.06%
1,603,491
-249,038
-13% -$5.52M
NTR icon
308
Nutrien
NTR
$30.7B
$32.2M 0.06%
685,794
-52,502
-7% -$2.74M
HEI.A icon
309
HEICO Corp Class A
HEI.A
$37.2B
$31.8M 0.06%
505,086
-3,795
-0.7% -$254K
CLX icon
310
Clorox
CLX
$12.7B
$31.8M 0.06%
206,021
+48,563
+31% +$7.57M
IWS icon
311
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$31.7M 0.06%
414,788
+160,936
+63% +$13.5M
IAU icon
312
iShares Gold Trust
IAU
$64.4B
$31.6M 0.06%
1,286,078
+51,748
+4% +$1.22M
TIP icon
313
iShares TIPS Bond ETF
TIP
$14.7B
$31.6M 0.06%
288,537
-46,495
-14% -$5.08M
CDK
314
DELISTED
CDK Global, Inc.
CDK
$31.4M 0.05%
656,277
+551,393
+526% +$29.1M
STAY
315
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$31.3M 0.05%
2,016,685
-169,601
-8% -$2.99M
ISRG icon
316
Intuitive Surgical
ISRG
$134B
$31.2M 0.05%
195,582
+59,832
+44% +$10.1M
STI
317
DELISTED
SunTrust Banks, Inc.
STI
$31.2M 0.05%
618,263
-18,270
-3% -$1.09M
RY icon
318
Royal Bank of Canada
RY
$293B
$31.1M 0.05%
454,775
-23,370
-5% -$1.71M
ELV icon
319
Elevance Health
ELV
$85.5B
$31M 0.05%
117,963
+26,054
+28% +$7.16M
BRO icon
320
Brown & Brown
BRO
$23.9B
$30.7M 0.05%
1,113,388
-30,796
-3% -$871K
HAL icon
321
Halliburton
HAL
$26.6B
$30.6M 0.05%
1,150,022
-341,572
-23% -$11.5M
CMI icon
322
Cummins
CMI
$88.7B
$30.2M 0.05%
225,947
+5,528
+3% +$780K
VMBS icon
323
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.7B
$29.8M 0.05%
579,674
+74,752
+15% +$3.79M
HPQ icon
324
HP
HPQ
$27.5B
$29.8M 0.05%
1,454,298
+90,831
+7% +$2.12M
QQEW icon
325
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.82B
$29.7M 0.05%
544,475
-101,678
-16% -$5.92M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.